# Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b

> **NCT02883647** · — · RECRUITING · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Hepatitis b

## Interventions

- **DRUG:** Entecavir or Tenofovir

## Key facts

- **NCT ID:** NCT02883647
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2014-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02883647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02883647, "Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02883647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*